MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$100.90
+0.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 56.82x
- P/S forward
- 8.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -628.64x
- Price / sales
- 10.60x
- Price / cash flow
- -14.37x
Enterprise value
- Enterprise value
- $6.9B
- EV / sales
- 11.12x
- EV / EBITDA
- -8.85x
- EV / EBIT
- -63.85x
- Market cap
- $6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026